All News

2019

June

Featured News / Jun 20, 2019

Pride @ Novartis 2019

As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.

Read More
Sickle cell disease patient, Nana, poses in Ghana to share her story
Featured News / Jun 19, 2019

World Sickle Cell Day 2019

For over 40 years Novartis has been committed to understanding sickle cell disease and working towards treatment.

Read More
Media Release / Jun 17, 2019

New analysis of Novartis data confirms that Cosentyx® demonstrates durable comprehensive treatment across psoriatic disease

Read More
Media Release / Jun 14, 2019

New Sandoz biosimilar adalimumab data confirms switching from reference biologic has no impact on safety or efficacy

Read More
Media Release / Jun 14, 2019

Novartis continues to innovate in CML with long-term treatment-free remission results following Tasigna® use and promising combination data with investigational compound asciminib (ABL001)

Read More
Media Release / Jun 13, 2019

Three quarters of people living with axial spondyloarthritis struggle to find a job, IMAS survey shows

Read More
Media Release / Jun 12, 2019

Cosentyx® provides long-lasting inhibition of radiographic progression in psoriatic arthritis, new Novartis data show

Read More
Media Release / Jun 12, 2019

Novartis Cosentyx® first to show efficacy in all key manifestations of psoriatic arthritis

Read More
Media Release / Jun 07, 2019

Novartis announces new leader of Pharmaceuticals Business Unit

Read More
Media Release / Jun 06, 2019

Advanced Accelerator Applications Receives Positive CHMP Opinion for LysaKare®

Read More

Pages

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More